Proteomic analysis of Caco-2 cells treated with monacolin K

Journal of Agricultural and Food Chemistry

Volumn 54, Issue 17, 2006, Pages 6192-6200

  Lin, Wun Yuan ^b   Song, Ching Yung ^b   Pan, Tzu Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b SHIH CHIEN UNIVERSITY   (Taiwan)

Author keywords

Anti cancer; Monacolin K; Monascus; Proteomics

Indexed keywords

ANTINEOPLASTIC AGENT; MEVINOLIN; TUMOR PROTEIN;

ARTICLE; CELL DIVISION; CELL STRAIN CACO 2; CELL SURVIVAL; CHEMISTRY; COLON TUMOR; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION; GENETICS; HUMAN; MASS SPECTROMETRY; PATHOLOGY; PROTEIN PROCESSING; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CACO-2 CELLS; CELL DIVISION; CELL SURVIVAL; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION; HUMANS; LOVASTATIN; NEOPLASM PROTEINS; PROTEIN ISOPRENYLATION; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

FUNGI; MONASCUS;

EID: 33748551339     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf061060c     Document Type: Article

References (69)

1. Wang, J. J.; Lee, C. L.; Pan, T. M. Improvement of monacolin K, gamma-aminobutyric acid and citrinin production ratio as a function of environmental conditions of Monascus purpureus NTU 601. J. Ind. Microbiol. Biotechnol. 2003, 30, 669-676.
2. Chen, F.; Hu, X. Study on red fermented rice with high concentration of monacolin K and low concentration of citrinin. Int. J. Food Microbiol. 2005, 103, 331-337.
3. Lee, H.; Park, H.; Kim, Y. J.; Kim, H. J.; Ahn, Y. M.; Park, B.; Park, J. H.; Lee, B. E. Expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in human preeclamptic placenta: possible implications in the process of trophoblast apoptosis. Placenta 2005, 26, 226-233.
4. Tanaka, T.; Akatsuka, S.; Ozeki, M.; Shirase, T.; Hiai, H.; Toyokuni, S. Redox regulation of annexin 2 and its implications for oxidative stress-induced renal carcinogenesis and metastasis. Oncogene 2004, 23, 3980-3989.
5. Shepherd, J.; Blauw, G. J.; Murphy, M. B.; Bollen, E. L.; Buckley, B. M.; Cobbe, S. M.; Ford, I.; Gaw, A.; Hyland, M.; Jukema, J. W.; Kamper, A. M.; Macfarlane, P. W.; Meinders, A. E.; Norrie, J.; Packard, C. J.; Perry, I. J.; Stott, D. J.; Sweeney, B. J.; Twomey, C.; Westendorp, R. G. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002, 360, 1623-1630.
6. Johnson, T. E.; Zhang, X.; Bleicher, K. B.; Dysart, G.; Loughlin, A. F.; Schaefer, W. H.; Umbenhauer, D. R. Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone. Toxicol. Appl. Pharmacol. 2004, 200, 237-250.
7. Etienne-Manneville, S.; Hall, A. Rho GTPases in cell biology. Nature 2002, 420, 629-635.
8. Mackay, D. J.; Hall, A. Rho GTPases. J Biol. Chem. 1998, 273, 20685-20688.
9. Bhattacharya, M.; Babwah, A. V.; Ferguson, S. S. Small GTP-binding protein-coupled receptors. Biochem. Soc. Trans. 2004, 32, 1040-1044.
10. Hippenstiel, S.; Kratz, T.; Krull, M.; Seybold, J.; von Eichel-Streiber, C.; Suttorp, N. Rho protein inhibition blocks protein kinase C translocation and activation. Biochem. Biophys. Res. Commun. 1998, 245, 830-834.
11. Su, Y. C.; Wang, J. J.; Lin, T. T.; Pan, T. M. Production of the secondary metabolites gamma-aminobutyric acid and monacolin K by Monascus J. Ind. Microbiol. Biotechnol. 2003, 30, 41-46.
12. Cafforio, P.; Dammacco, F.; Gernone, A.; Silvestris, F. Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. Carcinogenesis 2005, 26, 883-891.
13. Graaf, M. R.; Richel, D. J.; van Noorden, C. J.; Guchelaar, H. J. Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer. Cancer Treat. Rev. 2004, 30, 609-641.
14. Tojo, Y.; Bandoh, S.; Fujita, J.; Kubo, A.; Ishii, T.; Fukunaga, Y.; Ueda, Y.; Yang, Y.; Wu, F.; Huang, C. L.; Yokomise, H.; Ishida, T. Aberrant messenger RNA splicing of the cytokeratin 8 in lung cancer. Lung Cancer 2003, 42, 153-161.
15. Gagnaire, V.; Piot, M.; Camier, B.; Vissers, J. P.; Jan, G.; Leonil, J. Survey of bacterial proteins released in cheese: a proteomic approach. Int. J. Food Microbiol. 2004, 94, 185-201.
16. Konishi, Y.; Hitomi, Y.; Yoshida, M.; Yoshioka, E. Absorption and bioavailability of artepillin C in rats after oral administration. J. Agric. Food Chem. 2005, 53, 9928-9933.
17. Tarozzi, A.; Hrelia, S.; Angeloni, C.; Morroni, F.; Biagi, P.; Guardigli, M.; Cantelli-Forti, G.; Hrelia, P. Antioxidant effectiveness of organically and non-organically grown red oranges in cell culture systems. Eur. J. Nutr. 2006, 45, 152-158.
18. Gerlier, D.; Thomasset, N. Use of MTT colorimetric assay to measure cell activation. J. Immunol. Methods 1986, 94, 57-63.
19. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
20. Larner, J.; Jane, J.; Laws, E.; Packer, R.; Myers, C.; Shaffrey, M. A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme. Am. J. Clin. Oncol. 1998, 21, 579-583.
21. Lee, C. L.; Tsai, T. Y.; Wang, J. J.; Pan, T. M. In vivo hypolipidemic effects and safety of low dosage Monascus powder in a hamster model of hyperlipidemia. Appl. Microbiol. Biotechnol. 2006, 70, 533-540.
22. Skalnikova, H.; Halada, P.; Dzubak, P.; Hajduch, M.; Kovarova, H. Protein fingerprints of anti-cancer effects of cyclin-dependent kinase inhibition: identification of candidate biomarkers using 2-D liquid phase separation coupled to mass spectrometry. Technol. Cancer Res. Treat. 2005, 4, 447-454.
23. Hentosh, P.; Yuh, S. H.; Elson, C. E.; Peffley, D. M. Sterol-independent regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in tumor cells. Mol. Carcinog. 2001, 32, 154-166.
24. Hancock, J. F.; Magee, A. I.; Childs, J. E.; Marshall, C. J. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 1989, 57, 1167-1177.
25. Cau, J.; Hall, A. Cdc42 controls the polarity of the actin and microtubule cytoskeletons through two distinct signal transduction pathways. J. Cell Sci. 2005, 118, 2579-2587.
26. Hall, A. Rho GTPases and the actin cytoskeleton. Science 1998, 279, 509-514.
27. Mo, H.; Elson, C. E. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp. Biol. Med. (Maywood) 2004, 229, 567-585.
28. Alfonso, P.; Nunez, A.; Madoz-Gurpide, J.; Lombardia, L.; Sanchez, L.; Casal, J. I. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis. Proteomics 2005, 5, 2602-2611.
29. Turck, N.; Richert, S.; Gendry, P.; Stutzmann, J.; Kedinger, M.; Leize, E.; Simon-Assmann, P.; Van Dorsselaer, A.; Launay, J. F. Proteomic analysis of nuclear proteins from proliferative and differentiated human colonic intestinal epithelial cells. Proteomics 2004, 4, 93-105.
30. Savaraj, N.; Wei, Y.; Unate, H.; Liu, P. M.; Wu, C. J.; Wangpaichitr, M.; Xia, D.; Xu, H. J.; Hu, S. X.; Tien Kuo, M. Redox regulation of matrix metalloproteinase gene family in small cell lung cancer cells. Free Radical Res. 2005, 39, 373-381.
31. Henkle-Duhrsen, K.; Kampkotter, A. Antioxidant enzyme families in parasitic nematodes. Mol. Biochem. Parasitol. 2001, 114, 129-142.
32. Kinnula, V. L.; Lehtonen, S.; Sormunen, R.; Kaarteenaho-Wiik, R.; Kang, S. W.; Rhee, S. G.; Soini, Y. Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma. J. Pathol. 2002, 196, 316-323.
33. Hirotsu, S.; Hakoshima, T.; Abe, Y.; Nishino, T. Structural basis of peroxiredoxin functions: a new antioxidant protein family scavenging reactive oxygen species. Tanpakushitsu Kakusan Koso 2000, 45, 2463-2474.
34. Immenschuh, S.; Baumgart-Vogt, E. Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid. Redox Signaling 2005, 7, 768-777.
35. Lehtonen, S. T.; Svensk, A. M.; Soini, Y.; Paakko, P.; Hirvikoski, P.; Kang, S. W.; Saily, M.; Kinnula, V. L. Peroxiredoxins, a novel protein family in lung cancer. Int. J. Cancer 2004, 111, 514-521.
36. Oh, S. T.; Seo, J. S.; Moon, U. Y.; Kang, K. H.; Shin, D. J.; Yoon, S. K.; Kim, W. H.; Park, J. G.; Lee, S. K. A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer. Virology 2004, 320, 330-336.
37. Nonn, L.; Berggren, M.; Powis, G. Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. Mol. Cancer Res. 2003, 1, 682-689.
38. Karihtala, P.; Mantyniemi, A.; Kang, S. W.; Kinnula, V. L.; Soini, Y. Peroxiredoxins in breast carcinoma. Clin. Cancer Res. 2003, 9, 3418-3424.
39. Maeda, T.; Matsunuma, A.; Kurahashi, I.; Yanagawa, T.; Yoshida, H.; Horiuchi, N. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. J. Cell. Biochem. 2004, 92, 458-471.
40. Allen, S.; Heath, P. R.; Kirby, J.; Wharton, S. B.; Cookson, M. R.; Menzies, F. M.; Banks, R. E.; Shaw, P. J. Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways. J. Biol. Chem. 2003, 278, 6371-6383.
41. Cookson, M. S.; Reuter, V. E.; Linkov, I.; Fair, W. R. Glutathione S-transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue. J. Urol. 1997, 157, 673-676.
42. McIlwain, C. C.; Townsend, D. M.; Tew, K. D. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 2006, 25, 1639-1648.
43. Guo, Y. S.; Jin, G. F.; Houston, C. W.; Thompson, J. C.; Townsend, C. M., Jr. Insulin-like growth factor-I promotes multidrug resistance in MCLM colon cancer cells. J. Cell. Physiol. 1998, 175, 141-148.
44. Turella, P.; Cerella, C.; Filomeni, G.; Bullo, A.; De Maria, F.; Ghibelli, L.; Ciriolo, M. R.; Cianfriglia, M.; Mattei, M.; Federici, G.; Ricci, G.; Caccuri, A. M. Proapoptotic activity of new glutathione S-transferase inhibitors. Cancer Res. 2005, 65, 3751-3761.
45. 2-induced cell death via coordinated regulation of stress kinases. Cancer Res. 2000, 60, 4053-4057.
46. Kim, S.; Wong, P.; Coulombe, P. A. A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth. Nature 2006, 441, 362-365.
47. Pantel, K.; Dickmanns, A.; Zippelius, A.; Klein, C.; Shi, J.; Hoechtlen-Vollmar, W.; Schlimok, G.; Weckermann, D.; Oberneder, R.; Fanning, E.; et al. Establishment of micrometastatic carcinoma cell lines: a novel source of tumor cell vaccines. J. Natl. Cancer Inst. 1995, 87, 1162-1168.
48. Ferrer, A.; Marce, S.; Bellosillo, B.; Villamor, N.; Bosch, F.; Lopez-Guillermo, A.; Espinet, B.; Sole, F.; Montserrat, E.; Campo, E.; Colomer, D. Activation of mitochondrial apoptotic pathway in mantle cell lymphoma: high sensitivity to mitoxantrone in cases with functional DNA-damage response genes. Oncogene 2004, 23, 8941-8949.
49. Yinghao, Z.; Jun, W.; Yuanbo, C.; Jiachang, Y.; Xiaohong, F. Rotary torque produced by proton motive force in FoF1 motor. Biochem. Biophys. Res. Commun. 2005, 331, 370-374.
50. Copete, M. A.; Wendt, K.; Chen, S. Y. Expression of p53, Ki-67 and cytokeratin-4 (CK4) in oral papillomas. J. Oral Pathol. Med. 1997, 26, 211-216.
51. Svasti, J.; Srisomsap, C.; Subhasitanont, P.; Keeratichamroen, S.; Chokchaichamnankit, D.; Ngiwsara, L.; Chimnoi, N.; Pisutjaroenpong, S.; Techasakul, S.; Chen, S. T. Proteomic profiling of cholangiocarcinoma cell line treated with pomiferin from Derris malaccensis. Proteomics 2005, 5, 4504-4509.
52. 2+ homeostasis and apoptotic resistance of neuroendocrine- differentiated prostate cancer cells. Cell Death Differ. 2004, 11, 321-330.
53. Bursch, W.; Hochegger, K.; Torok, L.; Marian, B.; Ellinger, A.; Hermann, R. S. Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. J. Cell Sci. 2000, 113 (Pt 7), 1189-1198.
54. Kong, J. Y.; Rabkin, S. W. Cytoskeletal actin degradation induced by lovastatin in cardiomyocytes is mediated through caspase-2. Cell Biol. Int. 2004, 28, 781-790.
55. Saadi-Kheddouci, S.; Berrebi, D.; Romagnolo, B.; Cluzeaud, F.; Peuchmaur, M.; Kahn, A.; Vandewalle, A.; Perret, C. Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene. Oncogene 2001, 20, 5972-5981.
56. Noiva, R. Protein disulfide isomerase: the multifunctional redox chaperone of the endoplasmic reticulum. Semin. Cell Dev. Biol. 1999, 10, 481-493.
57. Bini, L.; Magi, B.; Marzocchi, B.; Arcuri, F.; Tripodi, S.; Cintorino, M.; Sanchez, J. C.; Frutiger, S.; Hughes, G.; Pallini, V.; Hochstrasser, D. F.; Tosi, P. Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis 1997, 18, 2832-2841.
58. Fukuda, T.; Chen, K.; Shi, X.; Wu, C. PINCH-1 is an obligate partner of integrin-linked kinase (ILK) functioning in cell shape modulation, motility, and survival. J. Biol. Chem. 2003, 278, 51324-51333.
59. Biven, K.; Erdal, H.; Hagg, M.; Ueno, T.; Zhou, R.; Lynch, M.; Rowley, B.; Wood, J.; Zhang, C.; Toi, M.; Shoshan, M. C.; Linder, S. A novel assay for discovery and characterization of pro-apoptotic drugs and for monitoring apoptosis in patient sera. Apoptosis 2003, 8, 263-268.
60. Gao, J.; Arbman, G.; Rearden, A.; Sun, X. F. Stromal staining for PINCH is an independent prognostic indicator in colorectal cancer. Neoplasia 2004, 6, 796-801.
61. Wang-Rodriguez, J.; Dreilinger, A. D.; Alsharabi, G. M.; Rearden, A. The signaling adapter protein PINCH is up-regulated in the stroma of common cancers, notably at invasive edges. Cancer 2002, 95, 1387-1395.
62. Charrier, L.; Jarry, A.; Toquet, C.; Bou-Hanna, C.; Chedorge, M.; Denis, M.; Vallette, G.; Laboisse, C. L. Growth phase-dependent expression of ICAD-L/DFF45 modulates the pattern of apoptosis in human colonic cancer cells. Cancer Res. 2002, 62, 2169-2174.
63. Al-Shawi, M. K.; Ketchum, C. J.; Nakamoto, R. K. Energy coupling, turnover, and stability of the F0F1 ATP synthase are dependent on the energy of interaction between gamma and beta subunits. J. Biol. Chem. 1997, 272, 2300-2306.
64. Roth, G. A.; Krenn, C.; Brunner, M.; Moser, B.; Ploder, M.; Spittler, A.; Pelinka, L.; Sautner, T.; Wolner, E.; Boltz-Nitulescu, G.; Ankersmit, H. J. Elevated serum levels of epithelial cell apoptosis-specific cytokeratin 18 neoepitope m30 in critically ill patients. Shock 2004, 22, 218-220.
65. Yang, W. L.; Addona, T.; Nair, D. G.; Qi, L.; Ravikumar, T. S. Apoptosis induced by cryo-injury in human colorectal cancer cells is associated with mitochondrial dysfunction. Int. J. Cancer 2003, 103, 360-369.
66. Balcerzak, M.; Hamade, E.; Zhang, L.; Pikula, S.; Azzar, G.; Radisson, J.; Bandorowicz-Pikula, J.; Buchet, R. The roles of annexins and alkaline phosphatase in mineralization process. Acta Biochim. Pol. 2003, 50, 1019-1038.
67. Liu, Z. L.; Luo, J. M.; Dong, Z. R.; Wang, F. X.; Zhang, X. J.; Yang, J. C.; Du, X. Y.; Yao, L. In vitro effects of mevastatin on the proliferation and apoptosis in human multiple myeloma cell line U266. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2004, 12, 340-345.
68. Lehnigk, U.; Zimmermann, U.; Woenckhaus, C.; Giebel, J. Localization of annexins I, II, IV and VII in whole prostate sections from radical prostatectomy patients. Histol. Histopathol. 2005, 20, 673-680.
69. Caplan, J. F.; Filipenko, N. R.; Fitzpatrick, S. L.; Waisman, D. M. Regulation of annexin A2 by reversible glutathionylation. J. Biol. Chem. 2004, 279, 7740-7750.